A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes

Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes

(2012) E. R. Mathiesen et al.   DIABETES CARE

Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes

(2011) Elisabeth R. Mathiesen et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Surveillance of adverse fetal effects of medications (SAFE-Med): Findings from the International Clearinghouse of Birth Defects Surveillance and Research

(2010) Alessandra Lisi et al.   REPRODUCTIVE TOXICOLOGY

Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes

(2008) R Bell et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

(2008) P. C. Bartley et al.   DIABETIC MEDICINE

Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients-The PREDICTIVE™ BMI clinical trial1

(2008) C. Fajardo Montañana et al.   DIABETIC MEDICINE

Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects

(2007) Moshe Hod et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY